Skip navigation
Agenda

Explore the Impact of Accumulator Programs, Copay Blocks and Point of Sale Rebates on Patient Affordability

October 2-3, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, OCTOBER 2, 2018

7:15

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Assess the Impact of Industry
Consolidations and Cost Shifts

8:30

PANEL Multi-stakeholder Perspectives on Addressing the Challenges of Drug Access and Affordability and the Future of Copay Programs

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

PANELISTS:

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals

Peter J. Pitts
former Associate Commissioner, FDA;
President, Center for Medicine in the Public Interest

Dina Inverso
Strategy Leader, Patient Engagement and Reimbursement
CSL Behring

Phillip W. McCreary, PharmD, MBA
Medication Access Program Director
Vanderbilt University Medical Center

Magda Rusinowski
Vice President, Health Care Cost and Delivery
National Business Group on Health

9:30

Understand Cost Shifting Trends in Drug Plan Benefit Design —
The Increase in Copay Accumulator Programs

Arran Standring
Data & Analytics Manager
McKesson Specialty Health

10:15

Refreshment Break

Understand Key Trends Affecting Market Access, Patient Affordability and the Future of the Drug Pricing Ecosystem

10:45

PANEL Explore Current Barriers to Prescription Drug Access and Assistance —
Patient Advocacy Perspectives

MODERATOR:

Dina Inverso
Strategy Leader, Patient Engagement and Reimbursement
CSL Behring

PANELISTS:

Carl Schmid
Deputy Executive Director
The AIDS Institute

Madelaine Feldman, MD
Rheumatologist
The Rheumatology Group

Kollet Koulianos
Senior Director, Patient Relations
National Hemophilia Foundation

11:30

Patient Assistance COEs — The Next Generation of Brand Support

David MacDougall
Practice Leader, US Market Access Strategy Consulting
IQVIA

Luke Greenwalt
General Manager, US Patient Access & Affordability Solutions
IQVIA

12:15

Networking Luncheon

1:15

Examine Key Trends in PBM and Manufacturer Relationships and Potential Impact on Patient Access

Peter J. Pitts
former Associate Commissioner, FDA;
President, Center for Medicine in the Public Interest

2:00

Rethinking Best Practices for Copay Program Design and Maintenance

Greg Zych
Director, Business Development
McKesson Specialty Health

2:45

Building Benefit Plan Designs for Patient Choice and Cost Management

Debbie L. Harrison
Assistant Director, Public Policy
National Business Group on Health

Tiffany McCaslin
Senior Analyst, Public Policy
National Business Group on Health

3:30

Networking Break

4:00 – 5:15

Choose Between Two Concurrent Breakout Sessions (A or B)

A. Primary Care Copay Programs Deep Dive
  • Understand the power of good data in ramping up a robust primary care copay program
  • Examine advanced adjudication models and complex offers
  • Evaluate patient engagement and enrollment strategies — Consider the benefits of intersecting CRM with your primary care model
  • Optimize current and new channels — Discuss best practices in channel management utilizing web, mobile, EHR and more
  • Review the impact of Real Time Benefit Check on copay program utilization and access
  • Assess the status of platforms and tools offering real-time patient specific information of plan coverage and medication costs

Bob Caprara
Vice President, Advanced Data Analytics and Chief Data Scientist
ConnectiveRx

Greg Pyszczymuka
Executive Director, Marketing and Channel Strategy
Aqua Pharmaceuticals

 
B. Specialty Brands Copay Programs Deep Dive
  • Examine key differentiators between specialty and primary care copay programs — Understand the varied levels of support required for specialty brands
  • Explore the costs of specialty assistance — Coinsurance versus copay
  • Consider managed care challenges of specialty products
  • Understand the unique flow of specialty products’ copay offer processing
  • Navigate cost shifts and the impact of accumulator programs
  • Determine copay program response to industry consolidations and mergers of payers, PBMs and specialty pharmacies
  • Design effective strategies to adjust copay programs to fit the specialty model

Mary-Beth Macaluso
former President, Macaluso Group;
EVP, Specialty Programs, ConnectiveRx

Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx

5:15

Assess the Role and Impact of PBM Discount and Pharmacy Cash Cards Programs

Paul LeVine
Vice President, Analytic Services
TrialCard

6:00

Close of Day One

Networking Cocktail Reception immediately following the final session on day one
Hosted By:

DAY TWO WEDNESDAY, OCTOBER 3, 2018

7:30

Continental Breakfast

8:15

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:30

ENFORCEMENT PANEL SESSION:Understand Compliance Trends within Patient Assistance Programs

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

PANELISTS:

David Eskew
Chief, Health Care & Government Fraud Unit
United States Attorney’s Office, District of New Jersey

William Weinreb
Assistant U.S. Attorney
U.S. Attorney’s Office, District of Massachusetts

Challenges in Copay Access and Reimbursement from Patient Advocacy, Pharmacy and Manufacturer Perspectives

9:30

Lightning Rounds Panel SessionDemystify Payment Models and Methods in Copay Systems Programs

Mary-Beth Macaluso
former President, Macaluso Group;
EVP, Specialty Programs, ConnectiveRx

Dan Hardin
Senior Vice President, General Manager, Pharmacy Benefit Solutions
Change Healthcare

10:15

Networking and Refreshment Break

10:45

Pharmacist Perspective — A View of Copay from the Ground Level

Dennis Murphy, PharmD
Manager, Commercial Strategy
Radius Health

11:30

PANELNavigating the Healthcare Landscape for Prescription Drug Access

MODERATOR:

Dennis Murphy, PharmD
Manager, Commercial Strategy
Radius Health

PANELISTS:

Karen Williams, PharmD
Medication Assistance Manager
Carilion Clinic

Phillip W. McCreary, PharmD, MBA
Medication Access Program Director
Vanderbilt University Medical Center

Natasha Gomes
Team Lead Financial Navigator
DuPage Medical Group

12:15

Networking Luncheon

1:30

Leverage eServices to Improve Access and Copay Card Utilization

Steve Mink
Vice President, Product Development
McKesson Specialty Health

2:15

Assess the Merits of Value-Based Contracts between Payers and Drug Manufacturers

Fred Brownfield
former Director, Pharma Innovative Contracting
Humana

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, OCTOBER 2, 2018

7:15

Registration and Continental Breakfast

8:15

Chairperson’s Welcome and Opening Remarks

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Assess the Impact of Industry
Consolidations and Cost Shifts

8:30

PANEL Multi-stakeholder Perspectives on Addressing the Challenges of Drug Access and Affordability and the Future of Copay Programs

MODERATOR:

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

PANELISTS:

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals

Peter J. Pitts
former Associate Commissioner, FDA;
President, Center for Medicine in the Public Interest

Dina Inverso
Strategy Leader, Patient Engagement and Reimbursement
CSL Behring

Phillip W. McCreary, PharmD, MBA
Medication Access Program Director
Vanderbilt University Medical Center

Magda Rusinowski
Vice President, Health Care Cost and Delivery
National Business Group on Health

9:30

Understand Cost Shifting Trends in Drug Plan Benefit Design —
The Increase in Copay Accumulator Programs

Arran Standring
Data & Analytics Manager
McKesson Specialty Health

10:15

Refreshment Break

Understand Key Trends Affecting Market Access, Patient Affordability and the Future of the Drug Pricing Ecosystem

10:45

PANEL Explore Current Barriers to Prescription Drug Access and Assistance —
Patient Advocacy Perspectives

MODERATOR:

Dina Inverso
Strategy Leader, Patient Engagement and Reimbursement
CSL Behring

PANELISTS:

Carl Schmid
Deputy Executive Director
The AIDS Institute

Madelaine Feldman, MD
Rheumatologist
The Rheumatology Group

Kollet Koulianos
Senior Director, Patient Relations
National Hemophilia Foundation

11:30

Patient Assistance COEs — The Next Generation of Brand Support

David MacDougall
Practice Leader, US Market Access Strategy Consulting
IQVIA

Luke Greenwalt
General Manager, US Patient Access & Affordability Solutions
IQVIA

12:15

Networking Luncheon

1:15

Examine Key Trends in PBM and Manufacturer Relationships and Potential Impact on Patient Access

Peter J. Pitts
former Associate Commissioner, FDA;
President, Center for Medicine in the Public Interest

2:00

Rethinking Best Practices for Copay Program Design and Maintenance

Greg Zych
Director, Business Development
McKesson Specialty Health

2:45

Building Benefit Plan Designs for Patient Choice and Cost Management

Debbie L. Harrison
Assistant Director, Public Policy
National Business Group on Health

Tiffany McCaslin
Senior Analyst, Public Policy
National Business Group on Health

3:30

Networking Break

4:00 – 5:15

Choose Between Two Concurrent Breakout Sessions (A or B)

A. Primary Care Copay Programs Deep Dive
  • Understand the power of good data in ramping up a robust primary care copay program
  • Examine advanced adjudication models and complex offers
  • Evaluate patient engagement and enrollment strategies — Consider the benefits of intersecting CRM with your primary care model
  • Optimize current and new channels — Discuss best practices in channel management utilizing web, mobile, EHR and more
  • Review the impact of Real Time Benefit Check on copay program utilization and access
  • Assess the status of platforms and tools offering real-time patient specific information of plan coverage and medication costs

Bob Caprara
Vice President, Advanced Data Analytics and Chief Data Scientist
ConnectiveRx

Greg Pyszczymuka
Executive Director, Marketing and Channel Strategy
Aqua Pharmaceuticals

 
B. Specialty Brands Copay Programs Deep Dive
  • Examine key differentiators between specialty and primary care copay programs — Understand the varied levels of support required for specialty brands
  • Explore the costs of specialty assistance — Coinsurance versus copay
  • Consider managed care challenges of specialty products
  • Understand the unique flow of specialty products’ copay offer processing
  • Navigate cost shifts and the impact of accumulator programs
  • Determine copay program response to industry consolidations and mergers of payers, PBMs and specialty pharmacies
  • Design effective strategies to adjust copay programs to fit the specialty model

Mary-Beth Macaluso
former President, Macaluso Group;
EVP, Specialty Programs, ConnectiveRx

Ticia Cawley
Vice President, Specialty Programs
ConnectiveRx

5:15

Assess the Role and Impact of PBM Discount and Pharmacy Cash Cards Programs

Paul LeVine
Vice President, Analytic Services
TrialCard

6:00

Close of Day One

Networking Cocktail Reception immediately following the final session on day one
Hosted By:

DAY TWO WEDNESDAY, OCTOBER 3, 2018

7:30

Continental Breakfast

8:15

Chairperson’s Review of Day One

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

8:30

ENFORCEMENT PANEL SESSION:Understand Compliance Trends within Patient Assistance Programs

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

PANELISTS:

David Eskew
Chief, Health Care & Government Fraud Unit
United States Attorney’s Office, District of New Jersey

William Weinreb
Assistant U.S. Attorney
U.S. Attorney’s Office, District of Massachusetts

Challenges in Copay Access and Reimbursement from Patient Advocacy, Pharmacy and Manufacturer Perspectives

9:30

Lightning Rounds Panel SessionDemystify Payment Models and Methods in Copay Systems Programs

Mary-Beth Macaluso
former President, Macaluso Group;
EVP, Specialty Programs, ConnectiveRx

Dan Hardin
Senior Vice President, General Manager, Pharmacy Benefit Solutions
Change Healthcare

10:15

Networking and Refreshment Break

10:45

Pharmacist Perspective — A View of Copay from the Ground Level

Dennis Murphy, PharmD
Manager, Commercial Strategy
Radius Health

11:30

PANELNavigating the Healthcare Landscape for Prescription Drug Access

MODERATOR:

Dennis Murphy, PharmD
Manager, Commercial Strategy
Radius Health

PANELISTS:

Karen Williams, PharmD
Medication Assistance Manager
Carilion Clinic

Phillip W. McCreary, PharmD, MBA
Medication Access Program Director
Vanderbilt University Medical Center

Natasha Gomes
Team Lead Financial Navigator
DuPage Medical Group

12:15

Networking Luncheon

1:30

Leverage eServices to Improve Access and Copay Card Utilization

Steve Mink
Vice President, Product Development
McKesson Specialty Health

2:15

Assess the Merits of Value-Based Contracts between Payers and Drug Manufacturers

Fred Brownfield
former Director, Pharma Innovative Contracting
Humana

3:00

Close of Conference